Stocks tumbled from their perch in mid-May and much of June as
the market fell into a correction on June 12.
After seven straight months of gains, the Nasdaq and S&P
500 were off just 1.5% in June.
This year through June, they're up 12.7% and 12.6%,
Managers of leading funds the past three months continued to
ease into discretionary stocks, includingKrispy Kreme Doughnuts (
) and the restaurant firmChuy's Holdings (
), in their latest reporting periods.
Personal care and vitamin supplement marketersUSANA Health
) andNu Skin Enterprises (
) also garnered buying from top funds.
As the economy shows signs of recovery, leisure travel booking
companies such asTripAdvisor (
),HomeAway (AWAY) andPriceline.com (PCLN) could continue to
benefit from Americans' love of traveling.
Top-performing funds have been investing in a handful of
medical issues:Illumina (ILMN),Questcor Pharmaceuticals
(QCOR),Actavis (ACT) andCigna (CI).
IBD spotted 12 best-performing funds that added Nu Skin,
investing an estimated $3.2 million as of their latest reporting
periods. The $46.1 billion Fidelity Growth Company Fund owned a
big stake in the firm.
The Provo, Utah-based company markets a suite of anti-aging
and nutritional products called ageLOC.
It sells products in 53 markets worldwide through direct
sales, with about 800,000 distributors.
It plans to launch the ageLOC TR90, a weight management and
body-shaping system, in the second half of the year.
The company believes this new product will be a big driver of
Nu Skin glowed with solid double-digit earnings growth the
past four quarters.
It recently raised full-year 2013 guidance to a range of $4.18
to $4.30 per share.
The stock consolidated for 59 weeks. It's trading near its buy
point of 63.45.
The country's top funds took profits in big aerospace defense
firmsBoeing (BA) andRockwell Collins (COL) in their latest
Boeing's sales growth slipped to 3% in Q1, the first
single-digit showing since Q3 2011.